Evaluation of Subantimicrobial Dose Doxycycline as an Adjunct to Scaling and Root Planing in Chronic Periodontitis Patients with Diabetes: A Randomized, Placebo-Controlled Clinical Trial
Satish Gupta, Manohar L. Bhongade, Vikas Deo, Ritika Jaiswal
Citation Information :
Gupta S, Bhongade ML, Deo V, Jaiswal R. Evaluation of Subantimicrobial Dose Doxycycline as an Adjunct to Scaling and Root Planing in Chronic Periodontitis Patients with Diabetes: A Randomized, Placebo-Controlled Clinical Trial. J Contemp Dent Pract 2010; 11 (3):9-16.
Diabetic patients have more severe periodontal destruction, but periodontal therapy can improve metabolic control. Recently, interest has focused on the use of subantimicrobial dose doxycycline (SDD) as a treatment paradigm. Therefore, this study was undertaken to evaluate clinical efficacy of SDD with scaling and root planning (SRP) in chronic periodontitis patients with diabetes.
Methods and Materials
Twenty chronic periodontitis patients with diabetes mellitus were randomly allocated to either a test and a control group. Clinical measurements were recorded at baseline and at six months for probing pocket depth (PPD), clinical attachment level (CAL), and gingival recession (GR). After SRP, patients in the test group were instructed to take SDD 20-mg capsules twice a day while patients in the control group took a placebo twice a day. Both groups were on this regimen for a six-month period.
Results
A greater reduction in mean PPD was demonstrated in patients in the test group compared to the control group. The mean CAL increase observed in the test group was significantly greater (0.67 mm) than that in the control group.
Conclusion
It can be concluded that SRP, in conjunction with the SDD therapy described, is more effective then SRP alone in terms of CAL gain and PPD reduction in diabetic patients with severe periodontal disease.
Clinical Significance
Given the widespread prevalence of both chronic periodontitis and diabetes, the proposed treatment approach will prove to be of great value and contribute significantly to the overall health of the patients.
Citation
Deo V, Gupta S, Bhongade ML, Jaiswal R. Evaluation of Subantimicrobial Dose Doxycycline as an Adjunct to Scaling and Root Planing in Chronic Periodontitis Patients with Diabetes: A Randomized, Placebo-Controlled Clinical Trial. J Contemp Dent Pract [Internet]. 2010 May; 11(3):009-016. Available from: http://www.thejcdp.com/journal/view/volume11- issue3-deo.
Diabetes mellitus and periodontal disease: two-year longitudinal observations. I. J Periodontol. 1970; 41(12):709-12.
The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol. 1992; 63(10):843-8.
Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997; 68(8):713-9.
The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol. 2001; 72(6):774-8.
A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997; 46(8):310-9.
Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol. 2000; 71(4):521-32.
Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol. 2002; 73(7):762-9.
Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial. J Periodontol. 2004; 75(8):1068-76.
Evaluation of efficacy of administration of sub-antimicrobial-dose doxycycline in the treatment of generalized adult periodontitis in diabetics. J Dent Res. 2003;82(Spec Iss A):1752.
Low-dose doxycycline treatment reduces glycosylated hemoglobin in patients with type 2 diabetes: a randomized controlled trial. J Dent Res. 2003;82(Spec Iss A):1445.
Reduced plaque formation by the chloromethyl analogue of vitamin C. J Periodontol. 1970; 41(1):41-3.
Psychological and chemical mediators of gingival health. J Prev Dent. 1977; 4(4):6-17.
The “cyclic” regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol. 1996; 67(5):506-14.
Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol. 2001; 28(2):146-56.
The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol. 2004; 75(1): 106-15.
Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol. 1995; 22(2):100-9.
Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol. 1993; 64(2):82-8.
Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis. J Clin Periodontol. 1984;11(1):63-76.
Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocininduced diabetic rats: a quantitative autoradiographic study. Calcif Tissue Int. 1992: 50(5):411-9.
Concentration of doxycycline in human gingival fluid. J Clin Periodontol. 1986: 13(9):841-44.
